Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Shylendra B Sreenivassappa"'
Autor:
Zachary D Crees, Caleb Shearrow, Leo Lin, Jennifer Girard, Kavin Arasi, Aayush Bhoraskar, Joseph Berei, Adam Eckburg, Austin D. Anderson, Christian Garcia, Ariana Munger, Sunil Palani, Thomas J Smith, Shylendra B Sreenivassappa, Connie Vitali, Odile David, Neelu Puri
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 12 (2020)
Background: EGFR/c-Met activation/amplification and co-expression, mTOR upregulation/activation, and Akt/Wnt signaling upregulation have been individually associated with more aggressive disease and characterized as potential prognostic markers for l
Externí odkaz:
https://doaj.org/article/8c227a1782da4256ae9803b9ba799ade
Autor:
Chike Osude, Leo Lin, Meet Patel, Adam Eckburg, Joseph Berei, Adijan Kuckovic, Namrata Dube, Aayush Rastogi, Shruti Gautam, Thomas J. Smith, Shylendra B. Sreenivassappa, Neelu Puri
Publikováno v:
Cells, Vol 11, Iss 10, p 1694 (2022)
NSCLC treatment includes targeting of EGFR with tyrosine kinase inhibitors (TKIs) such as Erlotinib; however, resistance to TKIs is commonly acquired through T790M EGFR mutations or overexpression of vascular endothelial growth factor receptor-2 (VEG
Externí odkaz:
https://doaj.org/article/aa83e90141d14f91a0783e80526c33ad
Autor:
Crees, Zachary D, Shearrow, Caleb, Lin, Leo, Girard, Jennifer, Kavin Arasi, Aayush Bhoraskar, Berei, Joseph, Eckburg, Adam, Anderson, Austin D., Garcia, Christian, Munger, Ariana, Palani, Sunil, Smith, Thomas J, Shylendra B Sreenivassappa, Vitali, Connie, David, Odile, Puri, Neelu
Supplemental material, Supplementary_Data_Final for EGFR/c-Met and mTOR signaling are predictors of survival in non-small cell lung cancer by Zachary D Crees, Caleb Shearrow, Leo Lin, Jennifer Girard, Kavin Arasi, Aayush Bhoraskar, Joseph Berei, Adam
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18c4a4b2d876e28e5f60d8459b1f73c6
